Inventor profile of:

Michael Rugaard Jensen

City:

Basel

Country:

Switzerland

Published Applications:

20

Last publication date:

2017-02-23

Top Assignees for applications by Michael Rugaard Jensen

The entities that hold a legal rights for patent applications filed by inventor Jensen Michael Rugaard:

Recent patent applications by Jensen Michael Rugaard

Michael Rugaard Jensen from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-02-23
US20170049781A1
Human necessities

HSP90 INHIBITOR COMBINATIONS

#2 | 2016-12-01
US20160346292A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#3 | 2016-08-04
US20160220576A1
Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#4 | 2016-02-18
US20160045513A1
Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#5 | 2015-07-30
US20150209362A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#6 | 2014-11-06
US20140328834A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#7 | 2014-09-25
US20140288075A1
Human necessities

Isoxazole compound for the treatment of cancer

#8 | 2014-08-28
US20140242088A1
Human necessities

Hsp90 inhibitor combinations

#9 | 2013-08-22
US20130217719A1
Human necessities

Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereof

#10 | 2013-04-04
US20130085153A1
Human necessities

COMBINATION OF AN IAP INHIBITOR AND A TAXANE FOR THE TREATMENT OF A PROLIFERATIVE DISEASE

#11 | 2013-02-21
US20130045983A1
Human necessities

HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT

#12 | 2012-08-30
US20120219550A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#13 | 2012-08-23
US20120214813A1
Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#14 | 2012-04-05
US20120083496A1
Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#15 | 2011-09-29
US20110236379A1
Human necessities

PHARMACEUTICAL COMBINATIONS COMPRISING A PYRIDO [4,3-D] PYRIMIDINE DERIVED HSP90-INHIBITOR AND A HER2 INHIBITOR

#16 | 2011-09-22
US20110230499A1
Human necessities

HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT

#17 | 2011-09-22
US20110230444A1
Human necessities

PHARMACEUTICAL COMBINATION COMPRISING A HSP 90 INHIBITOR AND A MTOR INHIBITOR

#18 | 2010-12-23
US20100324083A1
Human necessities

Combinations of Organic Compounds

#19 | 2010-08-19
US20100210650A1
Human necessities

ISOXAZOLE COMPOUND FOR THE TREATMENT OF CANCER

#20 | 2009-01-01
US20090005411A1
Human necessities

Combinations of Organic Compounds

InventorID:

102206 ⎘